BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9231056)

  • 21. Somatostatin receptor subtype gene expression in pituitary adenomas.
    Miller GM; Alexander JM; Bikkal HA; Katznelson L; Zervas NT; Klibanski A
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1386-92. PubMed ID: 7714115
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantification of Her-2/Neu gene in breast cancer patients using real time-polymerase chain reaction (Q-PCR) and correlation with immunohistochemistry findings.
    Abdul Murad NA; Razak ZA; Hussain RM; Syed Hussain SN; Ko Ching Huat C; Che Md Ali SA; Abdullah N; Muhammad R; Ibrahim N; Jamal R
    Asian Pac J Cancer Prev; 2013; 14(3):1655-9. PubMed ID: 23679251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. p16 (INK4a, MTS-1) gene polymorphism and methylation status in human pituitary tumours.
    Jaffrain-Rea ML; Ferretti E; Toniato E; Cannita K; Santoro A; Di Stefano D; Ricevuto E; Maroder M; Tamburrano G; Cantore G; Gulino A; Martinotti S
    Clin Endocrinol (Oxf); 1999 Sep; 51(3):317-25. PubMed ID: 10469011
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pit-1 gene expression in human pituitary adenomas using the reverse transcription polymerase chain reaction method.
    Yamada S; Takahashi M; Hara M; Hattori A; Sano T; Ozawa Y; Shishiba Y; Hirata K; Usui M
    Clin Endocrinol (Oxf); 1996 Sep; 45(3):263-72. PubMed ID: 8949563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EZH2 upregulation correlates with tumor invasiveness, proliferation, and angiogenesis in human pituitary adenomas.
    Liu B; Pang B; Wang Q; Yang S; Gao T; Ding Q; Liu H; Yang Y; Fan H; Zhang R; Xin T; Xu G; Pang Q
    Hum Pathol; 2017 Aug; 66():101-107. PubMed ID: 28666925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Matrix metalloproteinase-9, a potential biological marker in invasive pituitary adenomas.
    Gong J; Zhao Y; Abdel-Fattah R; Amos S; Xiao A; Lopes MB; Hussaini IM; Laws ER
    Pituitary; 2008; 11(1):37-48. PubMed ID: 17768685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of pituitary tumour-derived, N-terminally truncated isoform of fibroblast growth factor receptor 4 (ptd-FGFR4) correlates with tumour invasiveness but not with G-protein alpha subunit (gsp) mutation in human GH-secreting pituitary adenomas.
    Morita K; Takano K; Yasufuku-Takano J; Yamada S; Teramoto A; Takei M; Osamura RY; Sano T; Fujita T
    Clin Endocrinol (Oxf); 2008 Mar; 68(3):435-41. PubMed ID: 18070145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. B-RAF mutations are a rare event in pituitary adenomas.
    De Martino I; Fedele M; Palmieri D; Visone R; Cappabianca P; Wierinckx A; Trouillas J; Fusco A
    J Endocrinol Invest; 2007 Jan; 30(1):RC1-3. PubMed ID: 17318013
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Localization of vascular endothelial growth factor (VEGF) receptors in normal and adenomatous pituitaries: detection of a non-endothelial function of VEGF in pituitary tumours.
    Onofri C; Theodoropoulou M; Losa M; Uhl E; Lange M; Arzt E; Stalla GK; Renner U
    J Endocrinol; 2006 Oct; 191(1):249-61. PubMed ID: 17065408
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retinoid X receptor expression in the normal pituitary and clinically 'non-functioning' pituitary tumours.
    Gittoes NJ; McCabe CJ; Verhaeg J; Sheppard MC; Franklyn JA
    Clin Endocrinol (Oxf); 1998 Apr; 48(4):425-33. PubMed ID: 9640409
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Clinical Utility of TIMP3 Expression in ACTH-Secreting Pituitary Tumor.
    Sun B; Liu X; Yang Y; Dai C; Li Y; Jiao Y; Wei Z; Yao Y; Feng M; Bao X; Deng K; Wang N; Wang R
    J Mol Neurosci; 2016 Jan; 58(1):137-44. PubMed ID: 26676407
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression patterns of messenger ribonucleic acids encoding prohormone convertases (PC2 and PC3) in human pituitary adenomas.
    Hashimoto K; Koga M; Kouhara H; Arita N; Hayakawa T; Kishimoto T; Sato B
    Clin Endocrinol (Oxf); 1994 Aug; 41(2):185-91. PubMed ID: 7923822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apoptosis and p53 suppressor gene protein expression in human anterior pituitary adenomas.
    Green VL; White MC; Hipkin LJ; Jeffreys RV; Foy PM; Atkin SL
    Eur J Endocrinol; 1997 Apr; 136(4):382-7. PubMed ID: 9150697
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of c-erbB-2 amplification in salivary gland tumours by differential polymerase chain reaction.
    Birek C; Lui E; Jordan RC; Dardick I
    Eur J Cancer B Oral Oncol; 1994 Jan; 30B(1):47-50. PubMed ID: 9135973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Macrophage migration inhibitory factor expression is increased in pituitary adenoma cell nuclei.
    Pyle ME; Korbonits M; Gueorguiev M; Jordan S; Kola B; Morris DG; Meinhardt A; Powell MP; Claret FX; Zhang Q; Metz C; Bucala R; Grossman AB
    J Endocrinol; 2003 Jan; 176(1):103-10. PubMed ID: 12525254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oncogenic potential of c-erbB-2 and its association with c-K-ras in premalignant and malignant lesions of the human uterine endometrium.
    Manavi M; Bauer M; Baghestanian M; Berger A; Kucera E; Pischinger K; Battistutti W; Czerwenka K
    Tumour Biol; 2001; 22(5):299-309. PubMed ID: 11553860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpression of vasopressin (V3) and corticotrophin-releasing hormone receptor genes in corticotroph tumours.
    de Keyzer Y; René P; Beldjord C; Lenne F; Bertagna X
    Clin Endocrinol (Oxf); 1998 Oct; 49(4):475-82. PubMed ID: 9876345
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of interleukin-6, interleukin-6 receptor (gp80), and the receptor's signal-transducing subunit (gp130) in human normal pituitary glands and pituitary adenomas.
    Kurotani R; Yasuda M; Oyama K; Egashira N; Sugaya M; Teramoto A; Osamura RY
    Mod Pathol; 2001 Aug; 14(8):791-7. PubMed ID: 11504839
    [TBL] [Abstract][Full Text] [Related]  

  • 39. KIT protein expression and mutational status of KIT gene in pituitary adenomas.
    Casar-Borota O; Fougner SL; Bollerslev J; Nesland JM
    Virchows Arch; 2012 Feb; 460(2):171-81. PubMed ID: 22213031
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclin D and cyclin E expression in normal and adenomatous pituitary.
    Jordan S; Lidhar K; Korbonits M; Lowe DG; Grossman AB
    Eur J Endocrinol; 2000 Jul; 143(1):R1-6. PubMed ID: 10870044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.